Smoking reduction and biomarkers in two longitudinal studies

Addiction

Volumn 101, Issue 10, 2006, Pages 1516-1522

  Godtfredsen, Nina S ^a,b,f   Prescott, Eva ^a,c   Vestbo, Jørgen ^d   Osler, Merete ^e  

^a The Capital Region   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f NONE   (Denmark)

Author keywords

Biomarkers; Compensatory smoking; Smoking reduction; Validation study

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE;

ADULT; AGE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DATA ANALYSIS; EXPIRED AIR; FEMALE; FOLLOW UP; GENDER; HUMAN; INHALATION; LINEAR REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; PASSIVE SMOKING; QUESTIONNAIRE; SMOKING CESSATION; SMOKING HABIT; TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COTININE; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 33748354450     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01542.x     Document Type: Article

References (18)

1. Stratton K., Shetty P., Wallace R., Bondurant S. Clearing the smoke: the science base for tobacco harm reduction. Washington, DC: Institute of Medicine, National Academy Press; 2001. Available at: http://www.nap.edu/books/0209072824. html [accessed 2001].
2. Shields P. G. Tobacco smoking, harm reduction, and biomarkers. J Natl Cancer Inst 2002; 94: 1435-44.
3. Hatsukami D. K., Henningfield J. E., Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health 2004; 25: 377-95.
4. Bolliger C. T., Zellweger J.-P., Danielsson T., van Biljon X., Robidou A., Westin Å. et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000; 321: 329-33.
5. Eliasson B., Hjalmarson A., Kruse E., Landfeldt B., Westin Å. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tobacco Res 2001; 3: 249-55.
6. Fagerström K. O., Tejding R., Westin Å., MacKenzie T. D. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tobacco Control 1997; 6: 311-16.
7. Hurt R. D., Croghan G. A., Wolter T. D., Croghan I. T., Offord K. P., Williams G. M. et al. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tobacco Res 2000; 2: 327-36.
8. Benowitz N. L., Jacob P. III, Ahijevych K., Jarvis M. J., Hall S., LeHouezec J. et al. Biochemical verification of tobacco use and cessation. Nicotine Tobacco Res 2002; 4: 149-59.
9. Benowitz N. L., Jacob IIIP., Kozlowski L. T., YuL. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med 1986; 315: 1310-13.
10. Lynch C. J., Benowitz N. L. Spontaneous cigarette brand switching: consequences for nicotine and carbon monoxide exposure. Am J Public Health 1987; 77: 1191-4.
11. Rennard S. I., Daughton D., Fujita J., Oehlerking M. B., Dobson J. R., Stahl M. G. et al. Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. Eur Resp J 1990; 3: 752-9.
12. Appleyard M., Hansen A. T., Schnohr P., Jensen G., Nyboe J. A book of tables with data from the first examination 1976-78 and a 5-year follow-up 1981-83. The Copenhagen City Heart Study. Scand J Soc Med 1989; 170: 1-160.
13. Hein H. O., Suadicani P., Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ 1996; 312: 736-41.
14. Schnohr P., Jensen G., Lange P., Scharling H., Appleyard M. Tables with data from the third examination. The Copenhagen City Heart Study. Eur Heart J Suppl 2001; 3: H1-83.
15. Knight G. J., Wylie P., Holman M. S., Haddow J. E. Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem 1985; 31: 118-21.
16. StataCorp. Stata Statistical Software, release 7.0. College Station, TX: Stata Corporation, Stata Press; 2001.
17. Hughes J. R., Carpenter M. J. The feasibility of smoking reduction: an update. Addiction, 2005; 100: 1074-89.
18. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl) 1999; 145: 1-20.